Epidemiological studies have suggested that exposure to drugs such as nicotine and marijuana during adolescence is correlated with a significantly higher incidence of subsequent use of other drugs such as cocaine. In addition, there are different responses between female and male adolescents in response to drug use.Animal laboratory studies have shown that female and male rats respond differently to drugs and that the neurochemical adaptations that occur also differ. Studies have shown that drug administration during adolescence leads to differential neurochemical and behavioral effects than drug administration during adulthood. In addition, many of the effects of drugs during this critical developmental period have long- lasting effects that persist into adulthood. In general, the studies suggest that there may be an increased vulnerability to the effects of drugs during adolescence and that the effects differ across both sex andage. The main hypothesis of this proposal is that females and males will respond differently to drugs during different stages of development and that it may therefore be necessary to develop sex-and age-specific treatments for drug addiction. The focus of this proposal is to study the effects of nicotine, marijuana(A9- THC) and cocaine in female and male adolescent and adult rats on behavior and neurochemistry during adolescence and later during adulthood. In addition, the effects of environment on the changes produced by these drugs will be examined. An understanding of the differential effects of drugs in females and males during adolescence, and of how these changes use impact drug effects in adults may lead to sex-andage- specific treatments for drug addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA024584-05
Application #
8321588
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
2014-08-31
Budget Start
2011-09-01
Budget End
2013-08-31
Support Year
5
Fiscal Year
2011
Total Cost
$382,402
Indirect Cost
Name
University of Miami School of Medicine
Department
Type
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Spadola, Christine E; Wagner, Eric F; Accornero, Veronica H et al. (2017) Alcohol use patterns and alcohol use disorders among young adult, ethnically diverse bariatric surgery patients. Subst Abus 38:82-87
Silverman, Nora Siegal; Popp, Susanna; Vialou, Vincent et al. (2016) Effects of gaboxadol on the expression of cocaine sensitization in rats. Exp Clin Psychopharmacol 24:131-41
Messiah, Sarah E; Ludwig, David A; Vidot, Denise C et al. (2015) Prenatal Cocaine Exposure and Cardiometabolic Disease Risk Factors in 18- to 20-Year-Old African Americans. Ethn Dis 25:419-26
Lenoir, Magalie; Starosciak, Amy K; Ledon, Jennifer et al. (2015) Sex differences in conditioned nicotine reward are age-specific. Pharmacol Biochem Behav 132:56-62
Cue, Lauren; Diaz, Francisca; Briegel, Karoline J et al. (2015) Periodic Estrogen Receptor-Beta Activation: A Novel Approach to Prevent Ischemic Brain Damage. Neurochem Res 40:2009-17
Dow-Edwards, Diana; Iijima, Maiko; Stephenson, Stacy et al. (2014) The effects of prenatal cocaine, post-weaning housing and sex on conditioned place preference in adolescent rats. Psychopharmacology (Berl) 231:1543-55
Raval, Ami P; Borges-Garcia, Raquel; Diaz, Francisca et al. (2013) Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain. Transl Stroke Res 4:402-12
Raval, Ami P; Borges-Garcia, Raquel; Javier Moreno, William et al. (2013) Periodic 17?-estradiol pretreatment protects rat brain from cerebral ischemic damage via estrogen receptor-?. PLoS One 8:e60716
Vidot, D C; Arheart, K L; Prado, G et al. (2013) Illicit drug use and cardiometabolic disease risk: an analysis of 2005-2008 National Health and Nutrition Examination Survey data. Int J Clin Pract 67:1173-81
Mansoor, Elana; Morrow, Connie E; Accornero, Veronica H et al. (2012) Longitudinal effects of prenatal cocaine use on mother-child interactions at ages 3 and 5 years. J Dev Behav Pediatr 33:32-41

Showing the most recent 10 out of 25 publications